No Detail Found!

Biopolymeric nanoencapsulation of model drug: Its development and characterisation

Author(s)
Sushant Kumar Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences,Saifai, Etawah, UP,India
Nookala Venkata Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences,Saifai, Etawah, UP,India
Satheesh Madhav Formulation Research and Development, Vital Therapaeutics,Telangana, A.P.,India
Swarnima Pandey Department of Pharmacy, Hygia Group of Institutions of Pharmaceutical Education and Research,UP,India
Abstract
This research aimed to develop the phenytoin-loaded bionanosuspension by utilising the novel biopolymer from Juglans regia andreduce the long-term treatment cost of epilepsy and increase the efficiency of therapy. A novel biopolymer with remarkable inbuilt properties was isolated and used in the development of a nano capsulated dispersed system. The diverse proportions of phenytoin and biopolymer with different ratios 1:2, 1:3, 1:4, 1:5 and 1:8 were taken for the planning of details PJNC1-PJNC5. The bionanosuspension was assessed for dispersibility, pH, % entrapment efficiency, stability study and in vitro drug discharge. The formulation PJNC2 with 1:3 drug biopolymer proportion showed significant outcomes for various assessments with t50% of 16.51 h and r2 estimation of 0.9884. PJNC2 showed 92.07%±2.5 drug delivery in 36h and was stable. The bionanosuspension was found to be stable and safe for the delivery of nanosized phenytoin utilising the biopolymer having a remarkable stabiliser cum retardant property.
Publication Details
Page(s) 85-94
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Epilepsy, bionanoparticles, biopolymer, nanosizing, bionanosuspension, Juglans regia seeds
0

Citations

0

Downloads

106

Views